Date: Tuesday 4th March
Time: 12:30-14:00pm
Venue: Clifford Allbutt Building, Cambridge Biomedical Campus, CB2 0AH
Register at: https://eci-seminar-karl-smith-byrne.eventbrite.co.uk
The ECI seminar series aims to highlight early cancer related research across a range of disciplines, promote discussion and inspire new ideas and connections. Join fellow researchers for lunch and an opportunity to network.
On Tuesday 4th March we are joined by Dr Karl Smith-Byrne, Senior Molecular Epidemiologist at the Cancer Epidemiology Unit (CEU) at the University of Oxford.
Karl will speak on: Proteomics and cancer and mortality within large-scale prospective cohorts
This event will take place in the Clifford Allbutt Building lecture theatre, Cambridge Biomedical Campus, Cambridge, CB2 0AH.
A buffet lunch will be served from 12.30pm in the foyer outside the lecture theatre and the talk will begin at 1.00pm followed by a Q&A. Please ensure you arrive promptly.
Please note that no food or drink may be taken into the lecture theatre.
Speaker biography
Karl works as a senior molecular epidemiologist at the Cancer Epidemiology Unit (CEU) at the University of Oxford, and is also a research fellow at Green Templeton College.
He co-leads the metabolomics and proteomics research programme into the aetiology of prostate cancer using an integrative multi-omits approach and leads on the exome sequencing cohort within the Million Women Study. He also co-leads proteomics as part of a large European initiative, DISCERN, that focuses on understanding the causes of pancreatic, renal, and colorectal cancer.
He completed his post-doctoral work at the Genomic Epidemiology Branch of the International Agency for Research on Cancer in Lyon, France. There, he focussed on implementing multi-omic methods to better understand factors contributing to the aetiology, early detection, and prognosis of various cancers, in particular, lung and renal neoplasms. Karl completed his DPhil in Population Health at the University of Oxford, focussing on the molecular epidemiology of prostate cancer, with a focus on genetics and proteomics.
Before that, he acquired a MPhil in Biological Anthropology with a focus on human evolutionary perspectives on cancer genomics at the University of Cambridge.
Karl also read for a BSc in Psychology with a focus on cognitive neuroscience and behavioural ecology at the University of Dundee.